Zeke Capital Advisors, LLC Gsk PLC Transaction History

Zeke Capital Advisors, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$42.05 - $47.77 $542,907 - $616,758	-12,911 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$40.23 - $47.74 $79,414 - $94,238	1,974 Added 18.05%	12,911 $563,000
Q4 2021 Feb 14, 2022	BUY	$38.88 - $45.31 $43,895 - $51,154	1,129 Added 11.51%	10,937 $482,000
Q3 2021 Nov 15, 2021	SELL	$38.79 - $43.16 $19,395 - $21,580	-500 Reduced 4.85%	9,808 $375,000
Q2 2021 Aug 16, 2021	SELL	$36.52 - $41.46 $9,458 - $10,738	-259 Reduced 2.45%	10,308 $410,000
Q1 2021 Apr 21, 2021	BUY	$34.27 - $40.01 $4,934 - $5,761	144 Added 1.38%	10,567 $377,000
Q4 2020 Feb 10, 2021	SELL	$34.07 - $39.94 $92,465 - $108,397	-2,714 Reduced 20.66%	10,423 $384,000
Q3 2020 Nov 09, 2020	SELL	$38.11 - $42.99 $44,055 - $49,696	-1,156 Reduced 8.09%	13,137 $494,000
Q2 2020 Jul 21, 2020	SELL	$37.87 - $43.58 $3,484 - $4,009	-92 Reduced 0.64%	14,293 $583,000
Q1 2020 Apr 24, 2020	SELL	$32.47 - $48.83 $1.44 Million - $2.17 Million	-44,412 Reduced 75.53%	14,385 $545,000
Q4 2019 Jan 17, 2020	SELL	$42.0 - $48.25 $281,274 - $323,130	-6,697 Reduced 10.23%	58,797 $2.76 Million
Q3 2019 Oct 18, 2019	SELL	$40.46 - $43.52 $7,970 - $8,573	-197 Reduced 0.3%	65,494 $2.8 Million
Q2 2019 Jul 24, 2019	BUY	$39.4 - $42.7 $62,055 - $67,252	1,575 Added 2.46%	65,691 $2.63 Million
Q1 2019 Apr 29, 2019	BUY	$38.57 - $42.69 $673,085 - $744,983	17,451 Added 37.4%	64,116 $2.68 Million
Q4 2018 Feb 11, 2019	BUY	$37.8 - $42.69 $1.76 Million - $1.99 Million	46,665 New	46,665 $1.78 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Zeke Capital Advisors, LLC with notifications on news.